|
|
|
| Programme preview |
•
Sunday, September 13: Family Day from 9:00 am to 6:30 pm
• Monday, September 14: Conference from 9:00 am to 6:30 pm, Registration opens at 8:15
• Tuesday, September 15: Conference from 8:30 am to 5:30 pm, Gala at 7:00 pm
• Wednesday, September 16: Conference from 9:00 to 1:00 pm, Training session for French professionals
from 2:00 pm to 5:30 pm |
Please discover below our guest speakers:
 |
From individual susceptibility
to common mechanisms:
how genetics and epigenetics shed light on our understanding
of FASD |
 |
Challenges and pitfalls of estimating FASD prevalence:
share of fetal alcohol harm
to common but substantial neurodevelopmental hazard |
Dr. Nina Kaminen-Ahola,
University of Helsinki, Finland |
Pr Jürgen Rehm, |
| DE/CA Hamburg, Toronto |
| Dr. Kaminen-Ahola is an Associate Professor in Epigenetics in the Department of Medical and Clinical Genetics, University of Helsinki, Finland. Her lab aims to understand how our phenotypes are formed by our genome, early life environment, and stochastic events. Her focus is on the epigenome and its role as a mediator of environmental influences. By revealing the molecular mechanisms of environmental-induced epigenetic alterations as well as their consequences on gene regulation and embryonic development, she will clarify the etiology of complex phenotypes in health and disorder. |
Pr. Jürgen Rehm is senior scientist in the Institute for Mental Health Policy Research at the Centre for Addiction and Mental Health (CAMH). He is a professor and inaugural chair of addiction policy in the Dalla Lana School of Public Health at the University of Toronto. He is a leader in generating and analyzing the scientific data needed to inform clinicians and policymakers on strategies to reduce alcohol-, tobacco-, and other drug-related harms. His recent research has more and more included interactions between socio-economic status, poverty and substance use, including analysis of policies and interventions with respect to reducing or increasing inequalities. |
 |
Whole-person, Whole-Community: Advancing comprehensive care and support for people with FASD |
 |
Multimodal brain phenotype in FASD: what do we learn from longitudinal birth cohorts? |
Natasha Reid,
University of Queensland,
Brisbane, Australia |
Ernesta Meintjes,
Cape Town, South Africa |
| Dr. Reid is a Clinical Psychologist and Senior Research Fellow at the Child Health Research Centre. She leads the Perinatal and Early Life Exposures Research Group which is dedicated to uncovering the foundational influences on lifelong health and well-being. Her research focuses on the critical impact of environmental, nutritional, substance exposures such as prenatal alcohol exposure, and psychosocial factors during the perinatal and early childhood periods on long-term health outcomes. By advancing our understanding of these early exposures, they aim to inform public health strategies, improve clinical practices, and ultimately enhance the health and well-being of future generations. Their work contributes to reducing the burden of chronic diseases and mental health disorders, promoting healthier developmental outcomes, intergenerational health benefits and fostering resilient communities. Her clinical research interest includes developing and implementing effective preventive interventions for prenatal exposures, improving assessment methods and accessibility to services and early detection for FASD, developing and implementing effective interventions to improve outcomes for children with FASD and their families. |
Pr. Meintjes is senior Biomedical Imaging Researcher, Director of the Cape Universities Body Imaging Centre MRI unit, Division of Biomedical Engineering, Acting Head of the Human Biology Department
Her research – in the field of Developmental Neuroscience, Neuroimaging, Neurophysiology & Neuroanatomy – focuses on developing motion-robust methods to acquire MRI, and the application of these methods to study diseases and conditions particularly relevant to South Africa, which include studies on the effects of prenatal insults and diseases, such as HIV, maternal alcohol or drug use during pregnancy, as well as antiretroviral drugs taken by HIV-infected pregnant women, on brain development.
|
|
|
|
|
